Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-12 4:20 pm Purchase | 2025-09-30 | 13G | Texas Ventures Acquisition III Corp TVA | Barclays PLC | 1,705,587 7.580% | 527,987 (+44.84%) | Filing History |
| 2025-11-12 4:18 pm Purchase | 2025-09-30 | 13G | NMP Acquisition Corp. NMP | Barclays PLC | 904,720 7.450% | 904,720 (New Position) | Filing History |
| 2025-11-12 4:15 pm Purchase | 2025-09-30 | 13G | Thayer Ventures Acquisition Corporation II Class A Ordinary Shares TVAI | Barclays PLC | 1,519,375 7.410% | 1,519,375 (New Position) | Filing History |
| 2025-11-12 4:08 pm Purchase | 2025-09-30 | 13G | Dune Acquisition Corporation II IPOD | Barclays PLC | 1,061,124 7.320% | 1,061,124 (New Position) | Filing History |
| 2025-11-12 4:07 pm Purchase | 2025-09-30 | 13G | Live Oak Acquisition Corp. V Class A Ordinary Shares LOKV | Barclays PLC | 1,640,460 7.130% | 388,101 (+30.99%) | Filing History |
| 2025-11-12 4:06 pm Purchase | 2025-09-30 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | Barclays PLC | 3,841,449 5.320% | 3,841,449 (New Position) | Filing History |
| 2025-11-12 4:06 pm Purchase | 2025-09-30 | 13G | Axiom Intelligence Acquisition Corp 1 AXIN | Barclays PLC | 1,087,616 5.270% | 1,087,616 (New Position) | Filing History |
| 2025-11-12 4:05 pm Purchase | 2025-09-30 | 13G | Core Scientific, Inc. CORZ | Barclays PLC | 16,203,350 5.270% | 16,203,350 (New Position) | Filing History |
| 2025-11-12 4:00 pm Purchase | 2025-09-30 | 13G | FG Merger Corp. FGMC | Barclays PLC | 540,000 5.240% | 540,000 (New Position) | Filing History |
| 2025-11-12 4:00 pm Purchase | 2025-09-30 | 13G | Wen Acquisition Corp Class A Ordinary Shares WENN | Barclays PLC | 1,573,202 5.240% | 1,573,202 (New Position) | Filing History |
| 2025-11-12 3:47 pm Purchase | 2025-09-30 | 13G | Cumulus Media Inc. CMLS | Barclays PLC | 897,445 5.230% | 897,445 (New Position) | Filing History |
| 2025-11-12 3:46 pm Purchase | 2025-09-30 | 13G | Shenandoah Telecommunications Company SHEN | Barclays PLC | 2,857,490 5.200% | 2,857,490 (New Position) | Filing History |
| 2025-11-12 3:46 pm Purchase | 2025-09-30 | 13G | Cal Redwood Acquisition Corp. Class A Ordinary Shares CRAQ | Barclays PLC | 1,209,200 5.110% | 1,209,200 (New Position) | Filing History |
| 2025-11-12 3:43 pm Purchase | 2025-09-30 | 13G | Vine Hill Capital Investment Corp. VCIC | Barclays PLC | 1,103,783 5.010% | 15,384 (+1.41%) | Filing History |
| 2025-11-12 3:35 pm Sale | 2025-09-30 | 13G | Myriad Genetics, Inc. MYGN | Barclays PLC | 3,939,238 4.230% | -960,713 (-19.61%) | Filing History |
| 2025-11-12 3:34 pm Sale | 2025-09-30 | 13G | Ironwood Pharmaceuticals, Inc. IRWD | Barclays PLC | 3,167,713 1.950% | -7,966,144 (-71.55%) | Filing History |
| 2025-11-12 3:34 pm Purchase | 2025-09-30 | 13G | IB Acquisition Corp. Common Stock IBAC | Barclays PLC | 459,219 8.000% | 459,219 (New Position) | Filing History |
| 2025-11-12 3:28 pm Purchase | 2025-09-30 | 13G | Sizzle Acquisition Corp. II SZZL | Barclays PLC | 1,629,026 6.900% | 290,000 (+21.66%) | Filing History |
| 2025-11-12 3:26 pm Purchase | 2025-09-30 | 13G | Jackson Acquisition Company II JACS | Barclays PLC | 1,623,321 6.800% | 260,434 (+19.11%) | Filing History |
| 2025-11-12 3:21 pm Purchase | 2025-09-30 | 13G | Everspin Technologies, Inc. MRAM | Barclays PLC | 1,544,267 6.820% | 331,071 (+27.29%) | Filing History |